ABL BIOTEC A/S: Financial statements 2022
CVR: 50811018
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
ABL BIOTEC A/S (CVR 50811018) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -156,457 and a net result of DKK -2,875,355 compared with DKK 3,731,358 the year before. Equity in the 2022 report amounted to DKK 26,333,063. The solvency ratio was 99.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -156,457
- Profit/Loss
- DKK -2,875,355
- Equity
- DKK 26,333,063
- Total Assets
- DKK 26,386,845
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -156 t. | -2.9 mio. | 26.3 mio. | 1 |
| 2021 | - | -130 t. | 3.7 mio. | 29.8 mio. | 1 |
| 2020 | - | -116 t. | 2.5 mio. | 26.6 mio. | 1 |
| 2019 | - | -114 t. | 3.3 mio. | 24.7 mio. | 1 |
| 2018 | - | -109 t. | -2 mio. | 21.5 mio. | 1 |
Official annual report
Keep an eye on ABL BIOTEC A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
ABL BIOTEC A/S has published its annual report for 2021. Gross profit came to DKK -130,033, and the net result was DKK 3,731,358.
About ABL BIOTEC A/S
ABL BIOTEC A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 1974. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Asger Bach-Larsen. The board consists of Kirsten Bach-Larsen (chair), Gitte Larsen and Rikke Dahl Andersson. The company is owned by Asger Bach-Larsen and Kirsten Bach-Larsen. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK -129,949 and a net result of DKK -116,723 compared with DKK 3,704,421 the year before. Equity in the 2025 report amounted to DKK 27,884,586.